MARC record from Internet Archive

LEADER: 06439cam 2200769 a 4500
001 ocm24376708
003 OCoLC
005 20181024074612.0
008 910821s1992 cau b 001 0 eng
010 $a 91005085
040 $aDNLM/DLC$beng$cDLC$dNLM$dDJB$dPSM$dBAKER$dBTCTA$dYDXCP$dOCLCG$dUBC$dGEBAY$dOCLCQ$dBDX$dGBVCP$dOCLCO$dOCLCF$dOCLCQ$dDHA$dOCLCA
016 7 $a9111079$2DNLM
019 $a24380067$a26672695$a27226798
020 $a0804716692$q(cloth ;$qalk. paper)
020 $a9780804716697$q(cloth ;$qalk. paper)
035 $a(OCoLC)24376708$z(OCoLC)24380067$z(OCoLC)26672695$z(OCoLC)27226798
043 $ad------
050 00 $aHD9674.D44$bS54 1992
060 00 $aQV 736$bS587b 1992
082 00 $a338.4/76151/091724$220
084 $a44.40$2bcl
084 $a338.4761519
100 1 $aSilverman, Milton,$d1910-
245 10 $aBad medicine :$bthe prescription drug industry in the Third World /$cMilton Silverman, Mia Lydecker, Philip R. Lee.
260 $aStanford, Calif. :$bStanford University Press,$c1992.
300 $axvii, 358 pages ;$c24 cm
336 $atext$btxt$2rdacontent
337 $aunmediated$bn$2rdamedia
338 $avolume$bnc$2rdacarrier
504 $aIncludes bibliographical references (pages 319-339) and index.
505 0 $aThe patients : health for all by, when? -- Drug labeling : how safe? how deadly? -- The companies : heroes or villains? -- The great generics controversy -- The dipyrone affair -- The case of the deadly pregnancy test -- Bangladesh and the noble experiment --The drug swindlers -- So shines a good deed -- Ammunition for the consumers -- Consumer power : the Hansson/Ciba-Geigy connection -- The essential role of government -- Hard choices.
520 $aThe pharmaceutical industry has long and vehemently insisted that it has the willingness, the dedication, and the ability to police itself to insure that the public will not be unnecessarily harmed or defrauded. As the record shows with painful clarity, however, virtually no industry or professional group has ever adequately policed itself, and the pharmaceutical industry is no exception. Where the most flagrant abuses have been exposed and corrected, major credit must probably be divided among the media that publicized the situation, consumer groups that applied pressure, government officials who took actions that were often unpopular, and individual members of the pharmaceutical industry who had the courage to face up to their social responsibilities. To this number should perhaps be added the three authors of this volume who have, in a series of books such as Pills, Profits, and Politics, The Drugging of America, and Prescriptions for Death: The Drugging of the Third World, exposed fraudulent practices by U.S. and multinational pharmaceutical companies. In this book, the authors turn their attention to what happened in Third World countries when, because of worldwide pressures, the multinational drug companies largely corrected their notorious abuses. On the basis of painstaking research, much of it conducted in a great many Third World countries, the authors conclude that a plethora of small local firms have filled the dishonest sales channels vacated by the multinationals. The authors show in great detail how local drug firms in the Third World have taken advantage of loose regulatory practices and unscrupulous behavior on the part of regional and national health care professionals to promote the sale of dangerous or worthless drugs as remedies for diseases for which they were never intended. Warnings of bad side effects are omitted from promotional literature, drugs are sold that have not had proper trials, and drug firms have often bribed government officials, doctors, and hospital administrators in order to gain favorable treatment in the importation and sale of their products. Among the many topics treated in this book are the controversy over inexpensive generic drugs (including disclosures of fraud and bribery in the U.S. Food and Drug Administration), the actions of consumer groups, and the key role of government in preventing abuses by drug firms. The authors describe a remarkable attempt in Bangladesh, one of the poorest of all the developing countries, to develop a high-quality local drug industry. They also present as case histories reports on three extremely important drug products or groups--the dipyrones (for control of pain and fever), high-dosage estrogen-progesterone hormone products (for use in pregnancy tests), and clioquinol or Enterovioform (for treatment of diarrhea)--all of which were or still are centers of worldwide, heated controversy.
650 0 $aPharmaceutical industry$xCorrupt practices$zDeveloping countries.
650 0 $aPharmaceutical policy$zDeveloping countries.
650 12 $aDeveloping Countries.
650 12 $aDrug Industry.
650 2 $aSocial Responsibility.
650 7 $aPharmaceutical industry$xCorrupt practices.$2fast$0(OCoLC)fst01060133
650 7 $aPharmaceutical policy.$2fast$0(OCoLC)fst01060194
651 7 $aDeveloping countries.$2fast$0(OCoLC)fst01242969
650 07 $aArzneimittelversorgung.$2swd
650 07 $aGesundheitspolitik.$2swd
650 07 $aPharmazeutische Industrie.$2swd
650 07 $aWirtschaftsethik.$2swd
651 7 $aEntwicklungsla nder.$2swd
653 0 $aPharmaceutical industry$aCorrupt practices$aDeveloping countries
653 0 $aPharmaceutical policy$aDeveloping countries
653 2 $aDrug Industry$astandards
700 1 $aLydecker, Mia,$d1926-
700 1 $aLee, Philip R.$q(Philip Randolph),$d1924-
856 41 $3Table of contents$uhttp://catdir.loc.gov/catdir/toc/cam027/91005085.html
856 41 $3Table of contents$uhttp://www.gbv.de/dms/bs/toc/025054546.pdf
856 42 $3Publisher description$uhttp://catdir.loc.gov/catdir/description/cam024/91005085.html
938 $aBaker & Taylor$bBKTY$c62.95$d62.95$i0804716692$n0002036213$sactive
938 $aBrodart$bBROD$n43863728$c$64.95
938 $aBaker and Taylor$bBTCP$n91005085$c$30.00
938 $aYBP Library Services$bYANK$n672005
029 1 $aAU@$b000008403386
029 1 $aGBVCP$b025054546
029 1 $aGEBAY$b1832321
029 1 $aHEBIS$b024568961
029 1 $aNLM$b9111079
029 1 $aNZ1$b3673383
029 1 $aYDXCP$b672005
029 1 $aNZ1$b2172
994 $aZ0$bP4A
948 $hNO HOLDINGS IN P4A - 470 OTHER HOLDINGS